Covance -

It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain.

Managing phases I–IV of drug development for pharmaceutical and biotech firms.

Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services: COVANCE

Are you interested in through the company, or Overview of Covance Clinical Research and Drug Discovery

This medication is unsafe during pregnancy and can cause serious harm to an unborn baby. It is an Angiotensin II Receptor Blocker (ARB)

Operating central laboratories for specimen testing and medical device verification.

Assisting companies with FDA filings and drug commercialization. In 2023, the clinical development portion was spun

Volunteers can find active clinical trials through the official Labcorp site or ClinicalTrials.gov . 2. Covance (The Medication)